eli lilly compounded tirzepatide demands doctors stop selling copycat weight-loss drugs Personalized Compounded Tirzepatide Treatment

Tirzepatide works by activating both GLP-1 and GIP receptors, which help control blood sugar, curb appetite, and enhance insulin production

The purpose of these studies was to assess whether semaglutide altered the exposure of co-administered drugs commonly prescribed for the treatment of various co-morbidities associated with T2D

Semaglutide (Ozempic) The same active ingredient as Wegovy but at a lower maximum dose (1mg or 2mg) and TGA-approved for type 2 diabetes, not weight management

PMID: 34609538

Benefits:restoring, tightening, firming

It acts as an agonist at GLP-1, GIP, and glucagon receptors to suppress appetite, delay gastric emptying, promote insulin release, and break down fats